EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic utility of blood inflammation biomarkers before and after treatment on the survival of patients with locally advanced non‐small cell lung cancer undergoing stereotactic body radiotherapy

Fang Fang, Zhen Jia iD, Hongliang Xie, Yangsen Cao, Xiaofei Zhu iD, Xiao Yu Yang, Xueling Guo, Huojun Zhang

The Clinical Respiratory Journal · 2024

DOI: 10.1111/crj.13749 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Clinical Respiratory Journal, 2024. Verfasst von Fang Fang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Changhai Hospital Affiliated to Navy Medical University, Shanghai, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Radiosurgery, Neutrophils. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Changhai Hospital, Navy Medical University, Shanghai Health Commission Leading Talent Program, Changhai Hospital Guhai Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective The neutrophil–lymphocyte ratio (NLR) and platelet–lymphocyte ratio (PLR) were significant and succinct indicators of systemic inflammation. We assessed the influence of stereotactic body radiotherapy (SBRT) on NLR and PLR in patients with locally advanced non‐small cell lung cancer (LA‐NSCLC).

Methods

We reviewed the medical data of patients with LA‐NSCLC who underwent SBRT between 1 January 2013 and 31 December 2018. NLR and PLR values recorded at pre‐ and post‐SBRT were examined. We assessed the correlation between pre/post‐SBRT NLR and PLR and survival outcomes. The decision tree evaluation was conducted using Chi‐square automatic detection.

Results

In total, 213 patients were included in the study with a median follow‐up duration of 40.00 (ranging from 5.28 to 100.70) months. Upon dichotomization by a median, we identified that post‐SBRT NLR > 5.5 and post‐SBRT PLR > 382.0 were negatively associated with shorter overall survival (OS). In the multivariate assessment, post‐SBRT PLR > 382.0 was the only factor. Based on post‐SBRT PLR, tumor locations, and tumor stage, we categorized patients into low, medium, or high‐risk groups.

Conclusions

Post‐SBRT PLR > 382.0 correlated with survival in patients undergoing SBRT. The decision tree model might play a role in future risk stratification to guide the clinical practice of individualized SBRT for LA‐NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsRadiosurgeryNeutrophilsInflammationHumansMaleFemaleAgedPrognosisMiddle AgedRetrospective StudiesLymphocytesAged, 80 and overBlood PlateletsLymphocyte CountPlatelet CountSurvival RateNeoplasm StagingBiomarkers, Tumor

Stichwörter der Autor:innen

neutrophil–lymphocyte rationon‐small cell lung cancerplatelet–lymphocyte ratiostereotactic body radiation therapy

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Radiation Oncology, Changhai Hospital Affiliated to Navy Medical University, Shanghai, China.
  • Department of Hepatic Surgery, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, China.

ORCID-Profile: Zhen Jia, Xiaofei Zhu

Förderung

  • Changhai Hospital, Navy Medical University
  • Shanghai Health Commission Leading Talent Program
  • Changhai Hospital Guhai Program

Zitieren

APA

Fang, F., Jia, Z., Xie, H., Cao, Y., Zhu, X., Yang, X. Y., Guo, X., & Zhang, H. (2024). Prognostic utility of blood inflammation biomarkers before and after treatment on the survival of patients with locally advanced non‐small cell lung cancer undergoing stereotactic body radiotherapy. The Clinical Respiratory Journal. https://doi.org/10.1111/crj.13749

Vancouver

Fang F, Jia Z, Xie H, Cao Y, Zhu X, Yang XY, et al. Prognostic utility of blood inflammation biomarkers before and after treatment on the survival of patients with locally advanced non‐small cell lung cancer undergoing stereotactic body radiotherapy. The Clinical Respiratory Journal. 2024. doi:10.1111/crj.13749

BibTeX
@article{Fang2024,
  author = {Fang, Fang and Jia, Zhen and Xie, Hongliang and Cao, Yangsen and Zhu, Xiaofei and Yang, Xiao Yu and Guo, Xueling and Zhang, Huojun},
  title = {Prognostic utility of blood inflammation biomarkers before and after treatment on the survival of patients with locally advanced non‐small cell lung cancer undergoing stereotactic body radiotherapy},
  journal = {The Clinical Respiratory Journal},
  year = {2024},
  doi = {10.1111/crj.13749}
}
Kostenlos starten →